Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cell Bio-Systems Inc. --DMGR.PK-- Announces Symbol Change to CBSI Effective 4/14/04.


Business Editors/Health/Medical Writers

SAN DIEGO--(BUSINESS WIRE)--April 13, 2004

The Following Symbol Change Will Become Effective 4/14/04

Date                     Old Symbol       New Symbol/Name
----------------------------------------------------------------------
4/14/04                  DMGR             CBSI/Cell Bio Systems Inc.


About Cell Bio-Systems Inc.

Cell Bio-Systems Inc., a Nevada Corporation, through its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 Cell Bio-Systems Inc. Delaware, is a Medical Device Biotechnology Company seeking to manufacture and distribute patented technologies for Plastic and Cosmetic Surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. , Biopsy, Orthopedic Surgery Orthopedic Surgery Definition

Orthopedic (sometimes spelled orthopaedic) surgery is surgery performed by a medical specialist, such as an orthopedist or orthopedic surgeon, trained to deal with problems that develop in the bones, joints, and ligaments
 and other Living Tissue Markets. Cell Bio-Systems has licensed patented and proprietary technology designed to secure connections in a closed system and increase living tissue survivability sur·viv·a·ble  
adj.
1. Capable of surviving: survivable organisms in a hostile environment.

2. That can be survived: a survivable, but very serious, illness.
 by changing the surfaces in which live tissue at a cellular level comes in contact with during a procedure. Every surface the live tissue contacts during its journey from source to destination must be at a minimum neutral if not positive to cell viability. Current instrumentation is damaging to live tissue. This is a critical element in determining a successful, low risk, predictable outcome. To answer this, Cell Bio-Systems has developed the Living Tissue Management System(TM)(LTMS LTMS Laugh to Myself ). LTMS is more than individual instruments; it is a concept of manipulating live tissue outside of the source (body) while achieving minimum damage at a cellular level in order to achieve a safe and successful outcome. The core product in this system is the LTMS Cannula cannula /can·nu·la/ (kan´u-lah) a tube for insertion into a vessel, duct, or cavity; during insertion its lumen is usually occupied by a trocar.

can·nu·la or can·u·la
n. pl.
. This front line device is used directly in the tissue source to both begin and or end the process of live tissue management. All of the other products and devices which have the sole purpose of supporting the LTMS Cannula will be part of LTMS products and devices.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 13, 2004
Words:275
Previous Article:HarperCollins Publishers Acquires Senator Bob Dole's Memoir of World War II.
Next Article:COPAN Systems Executive to Present on a New Approach to Disk-Based Storage at NASA / IEEE MSST 2004 Conference.



Related Articles
AKZO NOBEL'S DIOSYNTH ESTABLISHING U.S. BRIDGEHEAD.
CBSI -- the submetering professionals. (National Suppliers Council Profiles).
Tech Science Press launches two new journals.
Direct Music Group, Inc Announces Acquisition of Cell Bio-Systems, Inc. and Name Change.
REPEAT/Cell Bio-Systems Inc. --DMGR.PK-- Announces Symbol Change to CBSI Effective 4/14/04.
Cell Bio-Systems Approves Design Enhancement for 60cc Syringe Hub Adaptor.
Cell Bio-Systems CEO Featured on MacReport.net.
Cell Bio-Systems CEO Speaks to WallStreetReporter.
Cell Bio-Systems Launches Beta Production of Patented Injector.
Cell Bio-Systems Adds John Johnson to Board of Directors.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles